The NAACP on Friday moved to intervene in Purdue Pharma's chapter 11 case, arguing that communities of color should receive settlement proceeds stemming from the national opioid crisis, Reuters reported. The group's motion to intervene comes amid the OxyContin-maker's efforts in bankruptcy to bring in more support for a settlement of opioid litigation that it says is worth more than $10 billion. The company filed for chapter 11 in September 2019 aiming to resolve the litigation. In its filing, the NAACP argues that attention has been disproportionately paid to white suburban and rural areas affected by the epidemic, rather than communities of color that have endured similar harm. U.S. Bankruptcy Judge Robert Drain in New York will consider the group's request at a court hearing on Aug. 26.
